{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:08:05Z","timestamp":1788944885773,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08745-3","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T10:52:03Z","timestamp":1786013523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FAP-targeted ROS-responsive nanoparticles delivering siBTF3 modulate the TME to enhance immunotherapy in colorectal cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Feihu","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengchun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdie","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2402-8916","authenticated-orcid":false,"given":"Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"3","key":"8745_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA: A Cancer. J Clin. 2023;73(3):233\u201354. https:\/\/doi.org\/10.3322\/caac.21772.","journal-title":"J Clin"},{"issue":"9","key":"8745_CR2","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/s43018-024-00809-x","volume":"5","author":"Single-cell atlas","year":"2024","unstructured":"Single-cell atlas. defines distinct immune escape mechanisms in colorectal cancer. Nat Cancer. 2024;5(9):1292\u20133. https:\/\/doi.org\/10.1038\/s43018-024-00809-x.","journal-title":"Nat Cancer"},{"issue":"11","key":"8745_CR3","doi-asserted-by":"publisher","first-page":"113318","DOI":"10.1016\/j.celrep.2023.113318","volume":"42","author":"F Wang","year":"2023","unstructured":"Wang F, Qi Q, Qin B, Wang Y, Huang Y, Li Q, et al. Targeting VCP potentiates immune checkpoint therapy for colorectal cancer. Cell Rep. 2023;42(11):113318. https:\/\/doi.org\/10.1016\/j.celrep.2023.113318.","journal-title":"Cell Rep"},{"issue":"1","key":"8745_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","volume":"18","author":"H Jia","year":"2025","unstructured":"Jia H, Chen X, Zhang L, Chen M. Cancer associated fibroblasts in cancer development and therapy. J Hematol Oncol. 2025;18(1):36. https:\/\/doi.org\/10.1186\/s13045-025-01688-0.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"8745_CR5","doi-asserted-by":"publisher","first-page":"e010212","DOI":"10.1136\/jitc-2024-010212","volume":"13","author":"J Chen","year":"2025","unstructured":"Chen J, Zhou Y, Pang Y, Fu K, Luo Q, Sun L, et al. FAP-targeted radioligand therapy with (68)Ga\/(177)Lu-DOTA-2P(FAPI)(2) enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacy. J Immunother Cancer. 2025;13(1):e010212. https:\/\/doi.org\/10.1136\/jitc-2024-010212.","journal-title":"J Immunother Cancer"},{"issue":"18","key":"8745_CR6","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.3390\/cancers16183158","volume":"16","author":"R Shah","year":"2024","unstructured":"Shah R, Johnson KA, Lippert AEL, Kraus SG, Emmerich PB, Pasch CA, et al. Cancer-Associated Fibroblast Proteins as Potential Targets against Colorectal Cancers. Cancers (Basel). 2024;16(18):3158. https:\/\/doi.org\/10.3390\/cancers16183158.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"8745_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2967\/jnumed.124.268689","volume":"66","author":"R Wang","year":"2025","unstructured":"Wang R, Huang M, Wang W, Li M, Wang Y, Tian R. Preclinical Evaluation of (68)Ga\/(177)Lu-Labeled FAP-Targeted Peptide for Tumor Radiopharmaceutical Imaging and Therapy. J Nucl Med. 2025;66(2):250\u20136. https:\/\/doi.org\/10.2967\/jnumed.124.268689.","journal-title":"J Nucl Med"},{"issue":"9","key":"8745_CR8","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3727\/096504017x14886494526344","volume":"25","author":"DZ Zhang","year":"2017","unstructured":"Zhang DZ, Chen BH, Zhang LF, Cheng MK, Fang XJ, Wu XJ. Basic Transcription Factor 3 Is Required for Proliferation and Epithelial-Mesenchymal Transition via Regulation of FOXM1 and JAK2\/STAT3 Signaling in Gastric Cancer. Oncol Res. 2017;25(9):1453\u201362. https:\/\/doi.org\/10.3727\/096504017x14886494526344.","journal-title":"Oncol Res"},{"issue":"28","key":"8745_CR9","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.3748\/wjg.v19.i28.4495","volume":"19","author":"Q Liu","year":"2013","unstructured":"Liu Q, Zhou JP, Li B, Huang ZC, Dong HY, Li GY, et al. Basic transcription factor 3 is involved in gastric cancer development and progression. World J Gastroenterol. 2013;19(28):4495\u2013503. https:\/\/doi.org\/10.3748\/wjg.v19.i28.4495.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"8745_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3892\/ol.2018.9613","volume":"17","author":"X Li","year":"2019","unstructured":"Li X, Sui J, Xing J, Cao F, Wang H, Fu C, et al. Basic transcription factor 3 expression silencing attenuates colon cancer cell proliferation and migration in vitro. Oncol Lett. 2019;17(1):113\u20138. https:\/\/doi.org\/10.3892\/ol.2018.9613.","journal-title":"Oncol Lett"},{"issue":"7","key":"8745_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41419-019-1747-2","volume":"10","author":"Q Liu","year":"2019","unstructured":"Liu Q, Wu J, Lu T, Fang Z, Huang Z, Lu S, et al. Positive expression of basic transcription factor 3 predicts poor survival of colorectal cancer patients: possible mechanisms involved. Cell Death Dis. 2019;10(7):509. https:\/\/doi.org\/10.1038\/s41419-019-1747-2.","journal-title":"Cell Death Dis"},{"issue":"1","key":"8745_CR12","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41467-024-55721-w","volume":"16","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Feng Y, Jiang M, Yao Z, Wang J, Pan F, et al. Ionizable polymeric micelles (IPMs) for efficient siRNA delivery. Nat Commun. 2025;16(1):360. https:\/\/doi.org\/10.1038\/s41467-024-55721-w.","journal-title":"Nat Commun"},{"issue":"6","key":"8745_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00604-024-06401-5","volume":"191","author":"Y Wu","year":"2024","unstructured":"Wu Y, Shi XJ, Dai XY, Song TS, Li XL, Xie JJ. Biogated mesoporous silica nanoagents for inhibition of cell migration and combined cancer therapy. Mikrochim Acta. 2024;191(6):326. https:\/\/doi.org\/10.1007\/s00604-024-06401-5.","journal-title":"Mikrochim Acta"},{"key":"8745_CR14","doi-asserted-by":"publisher","first-page":"102226","DOI":"10.1016\/j.mtbio.2025.102226","volume":"34","author":"N Xu","year":"2025","unstructured":"Xu N, Chi Z, Zhang H, Wu J, Sun R, Tian C. CD11b-modified ROS\/pH-responsive nanoparticles co-deliver Dioscin and siRNA to improve cardiac repair after myocardial infarction by reducing neutrophil recruitment. Mater Today Bio. 2025;34:102226. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102226.","journal-title":"Mater Today Bio"},{"issue":"26","key":"8745_CR15","doi-asserted-by":"publisher","first-page":"e2404781","DOI":"10.1002\/adhm.202404781","volume":"14","author":"TB Huq","year":"2025","unstructured":"Huq TB, Anil Kumar Jeeja P, Dam SK, Das SS, Vivero-Escoto JL. Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy. Adv Healthc Mater. 2025;14(26):e2404781. https:\/\/doi.org\/10.1002\/adhm.202404781.","journal-title":"Adv Healthc Mater"},{"issue":"5","key":"8745_CR16","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.1021\/acsami.4c17559","volume":"17","author":"H Wang","year":"2025","unstructured":"Wang H, Huang X, Gao R, Li K, Li D, Xu Z, et al. Multifunctional Artificial Peroxisome Basing on Lactate Oxidase as a Self-Cascade Enhancing Active Oxygen Amplifier for Tumor Therapy. ACS Appl Mater Interfaces. 2025;17(5):7275\u201390. https:\/\/doi.org\/10.1021\/acsami.4c17559.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"23","key":"8745_CR17","doi-asserted-by":"publisher","first-page":"e2201319","DOI":"10.1002\/adhm.202201319","volume":"11","author":"D Ma","year":"2022","unstructured":"Ma D, Shen H, Chen F, Liu W, Zhao Y, Xiao Z, et al. Inflammatory Microenvironment-Responsive Nanomaterials Promote Spinal Cord Injury Repair by Targeting IRF5. Adv Healthc Mater. 2022;11(23):e2201319. https:\/\/doi.org\/10.1002\/adhm.202201319.","journal-title":"Adv Healthc Mater"},{"key":"8745_CR18","doi-asserted-by":"publisher","first-page":"165530","DOI":"10.1016\/j.cej.2025.165530","volume":"519","author":"R Tao","year":"2025","unstructured":"Tao R, Cai J, Duan H, Hua Y, Geng B, Qin J. Biodegradable MnO2-x sensitized hollow prussian blue for enhanced sono-immunotherapy through cascade amplification of ROS generation and activation of cGAS-STING pathway. Chem Eng J. 2025;519:165530. https:\/\/doi.org\/10.1016\/j.cej.2025.165530.","journal-title":"Chem Eng J"},{"issue":"15","key":"8745_CR19","doi-asserted-by":"publisher","first-page":"17022","DOI":"10.1021\/acsami.1c23412","volume":"14","author":"A Liu","year":"2022","unstructured":"Liu A, Liang C, Liu J, Huang Y, Wang M, Wang L. Reactive Oxygen SpeciesResponsive Lipid Nanoparticles for Effective RNAi and Corneal Neovascularization Therapy. ACS Appl Mater Interfaces. 2022;14(15):17022\u201331. https:\/\/doi.org\/10.1021\/acsami.1c23412.","journal-title":"ACS Appl Mater Interfaces"},{"key":"8745_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jconrel.2024.02.014","volume":"367","author":"M Bocci","year":"2024","unstructured":"Bocci M, Zana A, Principi L, Lucaroni L, Prati L, Gilardoni E, et al. In vivo activation of FAP-cleavable small molecule-drug conjugates for the targeted delivery of camptothecins and tubulin poisons to the tumor microenvironment. J Control Release. 2024;367:779\u201390. https:\/\/doi.org\/10.1016\/j.jconrel.2024.02.014.","journal-title":"J Control Release"},{"issue":"20","key":"8745_CR21","doi-asserted-by":"publisher","first-page":"12716","DOI":"10.1021\/acsnano.3c08993","volume":"18","author":"ZA Chen","year":"2024","unstructured":"Chen ZA, Wu CH, Wu SH, Huang CY, Mou CY, Wei KC, et al. Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood-Brain Barrier. ACS Nano. 2024;18(20):12716\u201336. https:\/\/doi.org\/10.1021\/acsnano.3c08993.","journal-title":"ACS Nano"},{"issue":"52","key":"8745_CR22","doi-asserted-by":"publisher","first-page":"e2410368","DOI":"10.1002\/adma.202410368","volume":"36","author":"X Cheng","year":"2024","unstructured":"Cheng X, Sui H, Chen F, Li C, Du M, Zhang S, et al. Nanomaterial-Mediated Reprogramming of Macrophages to Inhibit Refractory Muscle Fibrosis. Adv Mater. 2024;36(52):e2410368. https:\/\/doi.org\/10.1002\/adma.202410368.","journal-title":"Adv Mater"},{"issue":"17","key":"8745_CR23","doi-asserted-by":"publisher","first-page":"16308","DOI":"10.1021\/acsnano.3c07621","volume":"17","author":"A Noureddine","year":"2023","unstructured":"Noureddine A, Maestas-Olguin A, Tang L, Corman-Hijar JI, Olewine M, Krawchuck JA, et al. Future of Mesoporous Silica Nanoparticles in Nanomedicine: Protocol for Reproducible Synthesis, Characterization, Lipid Coating, and Loading of Therapeutics (Chemotherapeutic, Proteins, siRNA and mRNA). ACS Nano. 2023;17(17):16308\u201325. https:\/\/doi.org\/10.1021\/acsnano.3c07621.","journal-title":"ACS Nano"},{"key":"8745_CR24","doi-asserted-by":"publisher","unstructured":"Shao D, Li M, Wang Z, Zheng X, Lao YH, Chang Z, et al. Bioinspired diselenide-bridged mesoporous silica nanoparticles for dual-responsive protein delivery. Adv Mater. 2018;e1801198. https:\/\/doi.org\/10.1002\/adma.201801198.","DOI":"10.1002\/adma.201801198"},{"issue":"Pt 1","key":"8745_CR25","doi-asserted-by":"publisher","first-page":"133984","DOI":"10.1016\/j.ijbiomac.2024.133984","volume":"277","author":"A Kumar","year":"2024","unstructured":"Kumar A, Ahmed B, Kaur IP, Saha L. Exploring dose and downregulation dynamics in lipid nanoparticles based siRNA therapy: Systematic review and meta-analysis. Int J Biol Macromol. 2024;277(Pt 1):133984. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.133984.","journal-title":"Int J Biol Macromol"},{"key":"8745_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.canlet.2018.09.030","volume":"440\u2013441","author":"J Ding","year":"2019","unstructured":"Ding J, Wang X, Zhang Y, Sang X, Yi J, Liu C, et al. Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3K\u03b1 inhibition through the transcriptional regulation of ER\u03b1. Cancer Lett. 2019;440\u2013441:54\u201363. https:\/\/doi.org\/10.1016\/j.canlet.2018.09.030.","journal-title":"Cancer Lett"},{"issue":"12","key":"8745_CR27","doi-asserted-by":"publisher","first-page":"e84295","DOI":"10.1371\/journal.pone.0084295","volume":"8","author":"AJ Symes","year":"2013","unstructured":"Symes AJ, Eilertsen M, Millar M, Nariculam J, Freeman A, Notara M, et al. Quantitative analysis of BTF3, HINT1, NDRG1 and ODC1 protein over-expression in human prostate cancer tissue. PLoS ONE. 2013;8(12):e84295. https:\/\/doi.org\/10.1371\/journal.pone.0084295.","journal-title":"PLoS ONE"},{"issue":"4","key":"8745_CR28","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s13277-013-0745-8","volume":"34","author":"CJ Wang","year":"2013","unstructured":"Wang CJ, Fr\u00e5nbergh-Karlson H, Wang DW, Arbman G, Zhang H, Sun XF. Clinicopathological significance of BTF3 expression in colorectal cancer. Tumour Biol. 2013;34(4):2141\u20136. https:\/\/doi.org\/10.1007\/s13277-013-0745-8.","journal-title":"Tumour Biol"},{"key":"8745_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbrc.2020.12.060","volume":"537","author":"H Wang","year":"2021","unstructured":"Wang H, Gao L, Qi M, Su P, Xiong X, Zhao J, et al. BTF3 promotes stemness and inhibits Type\u2160Interferon signaling pathway in triple-negative breast cancer. Biochem Biophys Res Commun. 2021;537:22\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2020.12.060.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"8745_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3892\/mmr.2017.7850","volume":"17","author":"B Zheng","year":"2018","unstructured":"Zheng B, Peng J, Mollayup A, Bakri A, Guo L, Zheng J, et al. Construction of a prognostic prediction system for pancreatic ductal adenocarcinoma to investigate the key prognostic genes. Mol Med Rep. 2018;17(1):216\u201324. https:\/\/doi.org\/10.3892\/mmr.2017.7850.","journal-title":"Mol Med Rep"},{"issue":"1","key":"8745_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12935-022-02599-7","volume":"22","author":"B Feng","year":"2022","unstructured":"Feng B, Wu J, Shen B, Jiang F, Feng J. Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures. Cancer Cell Int. 2022;22(1):166. https:\/\/doi.org\/10.1186\/s12935-022-02599-7.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"8745_CR32","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.4251\/wjgo.v16.i5.1705","volume":"16","author":"D S\u00e1nchez-Ram\u00edrez","year":"2024","unstructured":"S\u00e1nchez-Ram\u00edrez D, Mendoza-Rodr\u00edguez MG, Alem\u00e1n OR, Candanedo-Gonz\u00e1lez FA, Rodr\u00edguez-Sosa M, Montesinos-Montesinos JJ, et al. Impact of STAT-signaling pathway on cancer-associated fibroblasts in colorectal cancer and its role in immunosuppression. World J Gastrointest Oncol. 2024;16(5):1705\u201324. https:\/\/doi.org\/10.4251\/wjgo.v16.i5.1705.","journal-title":"World J Gastrointest Oncol"},{"issue":"12","key":"8745_CR33","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1038\/s41588-025-02380-2","volume":"57","author":"A Henriques","year":"2025","unstructured":"Henriques A, Salvany-Celades M, Nieto P, Palomo-Ponce S, Sevillano M, Hernando-Momblona X, et al. TGF-\u03b2 builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1(+) macrophages. Nat Genet. 2025;57(12):3050\u201365. https:\/\/doi.org\/10.1038\/s41588-025-02380-2.","journal-title":"Nat Genet"},{"issue":"6","key":"8745_CR34","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.apsb.2021.03.027","volume":"11","author":"Q Xie","year":"2021","unstructured":"Xie Q, Ding J, Chen Y. Role of CD8(+) T lymphocyte cells: Interplay with stromal cells in tumor microenvironment. Acta Pharm Sin B. 2021;11(6):1365\u201378. https:\/\/doi.org\/10.1016\/j.apsb.2021.03.027.","journal-title":"Acta Pharm Sin B"},{"key":"8745_CR35","doi-asserted-by":"publisher","first-page":"118045","DOI":"10.1016\/j.biopha.2025.118045","volume":"186","author":"A Mahmoudi Gharehbaba","year":"2025","unstructured":"Mahmoudi Gharehbaba A, Soltanmohammadi F, Vandghanooni S, Eskandani M, Adibkia K. A comprehensive review on overcoming the multifaceted challenge of cancer multidrug resistance: The emerging role of mesoporous silica nanoparticles. Biomed Pharmacother. 2025;186:118045. https:\/\/doi.org\/10.1016\/j.biopha.2025.118045.","journal-title":"Biomed Pharmacother"},{"key":"8745_CR36","doi-asserted-by":"publisher","first-page":"101510","DOI":"10.1016\/j.jddst.2020.101510","volume":"57","author":"F Bahrami","year":"2020","unstructured":"Bahrami F, Abdekhodaie MJ, Behroozi F, Mehrvar M. Nano mesoporous silica for cancer treatment: ROS-responsive and redox-responsive carriers. J Drug Deliv Sci Technol. 2020;57:101510. https:\/\/doi.org\/10.1016\/j.jddst.2020.101510.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"Pt 3","key":"8745_CR37","doi-asserted-by":"publisher","first-page":"146353","DOI":"10.1016\/j.ijbiomac.2025.146353","volume":"321","author":"C Li","year":"2025","unstructured":"Li C, Zhang P, Cheng Q, Fu S, Qiu R, Wang R, et al. Fibronectin-assisted reactive oxygen species-responsive mesoporous silica-loaded epigallocatechin-3-gallate for treating diabetic nephropathy by enhancing autophagy and regulating M1-type macrophage polarization. Int J Biol Macromol. 2025;321(Pt 3):146353. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146353.","journal-title":"Int J Biol Macromol"},{"issue":"20","key":"8745_CR38","doi-asserted-by":"publisher","first-page":"19740","DOI":"10.1021\/acsnano.3c03195","volume":"17","author":"Y Huang","year":"2023","unstructured":"Huang Y, Nahar S, Alam MM, Hu S, McVicar DW, Yang D. Reactive Oxygen Species-Sensitive Biodegradable Mesoporous Silica Nanoparticles Harboring TheraVac Elicit Tumor-Specific Immunity for Colon Tumor Treatment. ACS Nano. 2023;17(20):19740\u201352. https:\/\/doi.org\/10.1021\/acsnano.3c03195.","journal-title":"ACS Nano"},{"issue":"4","key":"8745_CR39","doi-asserted-by":"publisher","first-page":"594","DOI":"10.2967\/jnumed.125.271452","volume":"67","author":"D Zboralski","year":"2026","unstructured":"Zboralski D, Osterkamp F, von Hacht JL, Bredenbeck A, H\u00f6hne A, Libera-K\u00f6rner J, et al. Preclinical Development of 3BP-3940, a Fibroblast Activation Protein-Targeted Cyclic Peptide-Based Radiotheranostic for Imaging and Therapy. J Nucl Med. 2026;67(4):594\u2013600. https:\/\/doi.org\/10.2967\/jnumed.125.271452.","journal-title":"J Nucl Med"},{"issue":"1","key":"8745_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12951-025-03217-0","volume":"23","author":"T Liao","year":"2025","unstructured":"Liao T, Chen X, Qiu F, Zhang X, Wu F, Zhao Z, et al. Regulation of cancer-associated fibroblasts for enhanced cancer immunotherapy using advanced functional nanomedicines: an updated review. J Nanobiotechnol. 2025;23(1):166. https:\/\/doi.org\/10.1186\/s12951-025-03217-0.","journal-title":"J Nanobiotechnol"},{"issue":"25","key":"8745_CR41","doi-asserted-by":"publisher","first-page":"eaaz4462","DOI":"10.1126\/sciadv.aaz4462","volume":"6","author":"X Hong","year":"2020","unstructured":"Hong X, Zhong X, Du G, Hou Y, Zhang Y, Zhang Z, et al. The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency. Sci Adv. 2020;6(25):eaaz4462. https:\/\/doi.org\/10.1126\/sciadv.aaz4462.","journal-title":"Sci Adv"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08745-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08745-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08745-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:32:46Z","timestamp":1788942766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08745-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8745"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08745-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments were granted approval by the Experimental Animal Ethics Committee of The First Affiliated Hospital of Naval Medical University. All methods were carried out in accordance with relevant guidelines and regulations. This study was carried out in compliance with the ARRIVE guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1161"}}